A CBD assay and a powder-handling specification answer different questions. Before comparing bulk CBD isolate offers, ask what the supplier means by particle size and density, how each value was measured, and whether the report describes the lot you intend to buy. A phrase such as “fine powder” does not give a quality team enough information to compare two offers.
This guide helps procurement and formulation teams build that comparison. It concerns documentation for unformulated CBD isolate, not finished-product dosing or a claim that one particle size suits every application. The worksheet below is an editorial template, not a validated procedure or Vetrux batch specification.
The cover image is an AI-generated laboratory illustration, not a photograph of Vetrux equipment or a test result.
1. Agree on what the particle-size result means
Particle size is a measurement result, not a description that can be compared without context. Different techniques may describe different equivalent dimensions, and number-weighted and volume-weighted distributions are not interchangeable. Malvern Panalytical's particle-characterization guide explains these distinctions.
For a volume-weighted distribution, Dv10, Dv50 and Dv90 identify the diameters below which 10%, 50% and 90% of the measured particle volume falls. Dv50 is the median by volume, not a maximum size. A single median also leaves the distribution's fine and coarse ends unspecified. These are general measurement definitions, not recommended CBD size limits. See the percentile section of Malvern's guide, also available in English on its regional site.
Ask the supplier to name the technique, report the units and distribution basis, and identify the sample-preparation procedure. If one offer provides a sieve result and another a laser-diffraction percentile, flag them as different kinds of evidence. Do not convert them into an apparent like-for-like ranking from the headline numbers alone.
2. Keep bulk density and tapped density separate
Untapped bulk density is sample mass divided by its occupied volume, including the spaces between particles. Tapped density is mass divided by the volume occupied after a specified mechanical tapping procedure. The International Pharmacopoeia's powder-density chapter also explains why handling history and the measurement method matter when reporting density.
Ask for both the value and its label: untapped or tapped, units, method reference and sample condition. A density figure without these details is an incomplete comparison. Referencing a pharmacopoeial method does not mean that every CBD product is governed by that pharmacopoeia or meets its requirements.
Here is a fictional arithmetic example, not measured Vetrux data. Suppose two powder samples each weigh 100 g. At an assumed untapped density of 0.40 g/mL, one occupies 250 mL; at 0.50 g/mL, the other occupies 200 mL. The calculation is simply volume = mass / density. Neither assumed value is a target specification, evidence of purity or a safe container-fill recommendation.
This is why a purchasing record should not treat equal net mass as proof of identical occupied volume. Actual packaging and equipment decisions still need their own assessment.
3. Use a method-and-result comparison worksheet
Send the same request to each candidate supplier. Mark an unanswered field as “not provided,” rather than interpreting silence as a passing result.
Scroll horizontally to view the full table.
| Record | Ask the supplier for | Note in your comparison |
|---|---|---|
| Material identity | Product code, grade, manufacturer and lot reference | Is the report about the offered material? |
| Particle-size result | Technique, units, distribution basis and reported values | Are the two results expressed on the same basis? |
| Preparation | Procedure reference and any dispersion or pre-treatment used for measurement | Can your laboratory reproduce the comparison? |
| Density | Untapped/tapped label, units, method and sample condition | Which reported value answers your handling question? |
| Sampling | Source lot, sampling date and link to the supplied sample | Is this a lot result or generic product information? |
| Specification status | Whether a value is typical, informational or an agreed acceptance criterion | What is actually being offered for this order? |
| Supporting report | Original report identifier, date and revision | Can the original evidence be retrieved later? |
Not every buyer needs every physical-property test. Start with a concrete question from your own process: perhaps whether a proposed material can be assessed against an approved powder, or whether a supplier's generic specification is sufficient to plan a trial. Ask your quality and formulation teams which evidence would change their decision.
If that question is already answered by an approved specification and suitable records, avoid adding tests merely to make the dossier longer.
4. Separate a documentation gap from a material failure
Consider two hypothetical offers. Supplier A supplies a size distribution with a method reference but no lot identifier. Supplier B supplies a lot-linked sieve result but no density report. Neither package yet answers the full comparison request. That is a reason to ask targeted follow-up questions, not evidence that either material has failed a test.
A useful review note records the missing item, its owner, the decision it affects and the evidence needed to close it. Keep the original reports when a revised document arrives; note what changed and why. Where methods differ, ask the responsible laboratory whether a meaningful comparison is possible or whether additional work is necessary.
If you are replacing an approved material, place this review inside your raw-material change-control record. Do not approve a supplier change solely because one size statistic matches.
5. Turn the findings into a focused trial or inquiry
Before ordering material for an application trial, write down what the trial must answer, the comparison material, the observations to record and who will decide whether the evidence is sufficient. Keep sample identity and document versions attached to that record. This article does not prescribe mixing conditions, acceptance limits or a universal sample count.
Particle-size and density records also do not replace a batch COA review. They add physical-property context to the separate identity, composition and other quality questions relevant to your intended use.
For a Vetrux inquiry, include the isolate grade you are considering, intended application and destination market, required quantity, and the specific particle-size or density information your team needs. Ask which records can be supplied for the proposed order. Availability of a particular measurement, sample or tailored specification must be confirmed; this guide does not promise that every listed test is routinely offered.
About the publisher
VETRUX Technical Content Team
CBD raw-material and sourcing context
VETRUX publishes practical material-handling, documentation, and supplier-qualification guidance from the perspective of a CBD raw-material supplier in Chuxiong, Yunnan.
Learn more about VETRUX →
